|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
69,022,000 |
Market
Cap: |
N/A |
Last
Volume: |
254,031 |
Avg
Vol: |
114,348 |
52
Week Range: |
$9.76 - $9.76 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) ![](../../images/information.jpg) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-03-28 |
2023-12-26 |
2023-06-27 |
2022-06-27 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Nielsen Kurt Anker |
Director |
|
2010-10-08 |
4 |
D |
$9.75 |
$29,250 |
D/D |
(3,000) |
0 |
|
- |
|
Penhoet Edward |
Director |
|
2010-10-08 |
4 |
D |
$9.75 |
$702,000 |
D/D |
(72,000) |
0 |
|
- |
|
Ramos Eleanor |
Sr. VP, Chief Medical Officer |
|
2010-10-08 |
4 |
D |
$9.75 |
$35,090 |
D/D |
(3,599) |
2,500 |
|
- |
|
Williams Douglas E |
Chief Executive Officer |
|
2010-10-08 |
4 |
D |
$9.75 |
$44,850 |
D/D |
(4,600) |
0 |
|
- |
|
Maccallum David |
Director |
|
2010-10-08 |
4 |
D |
$9.75 |
$97,500 |
D/D |
(10,000) |
0 |
|
- |
|
Jorgensen Lars Fruergaard |
Director |
|
2010-10-08 |
4 |
D |
$9.75 |
$224,346,145 |
I/I |
(23,009,861) |
0 |
|
- |
|
Miller Dennis M. |
Sr VP, Resrch & Preclin Devl |
|
2010-10-08 |
4 |
D |
$9.75 |
$35,090 |
D/D |
(3,599) |
2,500 |
|
- |
|
Hirsh David I |
Director |
|
2010-10-08 |
4 |
D |
$9.75 |
$281,775 |
D/D |
(28,900) |
0 |
|
- |
|
Johnson James A |
Executive VP and CFO |
|
2010-10-08 |
4 |
D |
$9.75 |
$253,685 |
D/D |
(26,019) |
0 |
|
- |
|
Harper James A |
Director |
|
2010-10-08 |
4 |
D |
$9.75 |
$39,000 |
D/D |
(4,000) |
0 |
|
- |
|
Franklin Heather L |
Sr. VP, Business Development |
|
2010-10-08 |
4 |
D |
$9.75 |
$49,725 |
D/D |
(5,100) |
2,500 |
|
- |
|
Carter Bruce L A |
Director |
|
2010-10-08 |
4 |
D |
$9.75 |
$4,570,313 |
D/D |
(468,750) |
115,399 |
|
- |
|
Hamby Darren R |
Sr. VP, HR & Corp Svcs |
|
2010-10-08 |
4 |
D |
$9.75 |
$975 |
D/D |
(100) |
0 |
|
- |
|
Novo Nordisk A S |
Former 10% owner |
|
2010-10-08 |
4 |
S |
$9.75 |
$215,897,370 |
D/D |
(22,143,320) |
0 |
|
- |
|
Zeus Acquisition Corp |
10% Owner |
|
2010-10-08 |
4 |
A |
$9.75 |
$805,403,908 |
I/I |
82,605,529 |
82,605,529 |
|
- |
|
Landy Joseph |
10% Owner |
|
2010-10-07 |
4 |
D |
$9.75 |
$91,528,700 |
D/D |
(9,387,559) |
0 |
|
- |
|
Leff Jonathan S |
Director |
|
2010-10-07 |
4 |
D |
$9.75 |
$91,528,700 |
I/I |
(9,387,559) |
0 |
|
- |
|
Johnson James A |
Executive VP and CFO |
|
2010-09-08 |
4 |
S |
$9.75 |
$195,000 |
D/D |
(20,000) |
26,019 |
|
- |
|
Johnson James A |
Executive VP and CFO |
|
2010-09-08 |
4 |
OE |
$2.78 |
$55,540 |
D/D |
20,000 |
46,019 |
|
- |
|
Carter Bruce L A |
Director |
|
2010-08-19 |
4 |
OE |
$2.78 |
$1,183,300 |
D/D |
426,000 |
584,149 |
|
- |
|
Penhoet Edward |
Director |
|
2010-08-17 |
4 |
OE |
$2.78 |
$199,994 |
D/D |
72,000 |
72,000 |
|
- |
|
Hamby Darren R |
Sr. VP, HR & Corp Svcs |
|
2010-07-30 |
4 |
S |
$3.96 |
$79,200 |
D/D |
(20,000) |
100 |
|
- |
|
Hamby Darren R |
Sr. VP, HR & Corp Svcs |
|
2010-07-30 |
4 |
OE |
$2.78 |
$55,540 |
D/D |
20,000 |
20,100 |
|
- |
|
Jorgensen Lars Fruergaard |
Director |
|
2010-06-17 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
23,009,861 |
|
- |
|
Ramos Eleanor |
Sr. VP, Chief Medical Officer |
|
2010-02-24 |
4 |
S |
$5.66 |
$3,747 |
D/D |
(662) |
6,099 |
|
- |
|
162 Records found
|
|
Page 1 of 7 |
|
|